Soleus Capital
Overview
Soleus Capital is a healthcare investment firm located in Greenwich, CT which manages hedge, private equity and credit funds primarily focused on the innovative areas of life sciences, including biotech, medtech, diagnostics, and genomics . The firm invests across the healthcare lifecycle from developmental-stage companies through commercial companies . Soleus Capital's primary investment strategy seeks superior risk-adjusted returns over time by investing in the healthcare sector .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Treeline Biosciences | Apr 2021 | Series A | Co-investor |
| Parabilis Medicines | Jan 2026 | Series F | Co-investor |
| Fog Pharmaceuticals | Jan 2026 | Series F | Co-investor |
| Jade Biosciences, Inc. | Apr 2025 | M&A | Co-investor |
| Beta Bionics | Nov 2024 | Series E | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Soleus Capital based?
Headquarters information for Soleus Capital is not publicly available.
When was Soleus Capital founded?
Soleus Capital was founded in 2018.
How many portfolio companies does Soleus Capital have?
Soleus Capital has 32 portfolio companies in Caplight's dataset.
What are some companies in Soleus Capital's portfolio?
Portfolio companies visible on Caplight include Treeline Biosciences, Parabilis Medicines, Fog Pharmaceuticals, Jade Biosciences, Inc., Beta Bionics.
What was Soleus Capital's most recent investment shown here?
Soleus Capital's most recent investment in this portfolio sample was in Parabilis Medicines in 2026.
What sectors does Soleus Capital focus on?
Soleus Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Soleus Capital focus on?
Soleus Capital typically invests at the Mid stage.
What is Soleus Capital's AUM?
Soleus Capital's assets under management are estimated between $1.0B and $10.0B.